Genomics in Cancer Care Market Share, Size, Trends, & Industry Analysis Report, By Product type (Consumables, Instruments, Services); By Technology, By Application; By End Use; and By Region: Segment Forecast, 2019 - 2025

报告摘要

2018年全球癌症护理市场规模的基因组学估值为47.011亿美元，预计2019年至2025年的复合年增长率为17.7%。基因组学在癌症治疗中的应用可以被定义为一种有希望的技术，通过专注于推进个体化医疗来准确诊断癌症。这项技术有助于对未来几年癌症治疗的效果和成本效益进行系统评估。癌症基因组学是一个相对较新的研究领域，它利用最新的技术进步来研究人类基因组，也就是说我们的全套DNA。通过对癌细胞的DNA和RNA进行测序，并将测序结果与血液等正常组织进行比较，科学家们发现了可能导致癌症的基因差异。

全球癌症基因组学护理行业是majorly driven by the in increasing number of patients suffering for cancer, and continuous technological advancements for innovating new types of technologies. Moreover, need for cost effective technology and accurate diagnosis of cancer would propel the genomic in cancer care market during the forecast period. In addition, increased adoption of these technologies in the research labs & institutes, and technological innovations for overcoming certain drawbacks of will augment the growth of the particular market during the forecast period.

了解有关此报告的更多信息：样本页请求

由于基因组学的应用和现代设备和服务的技术进步，基因组测序正在显著增长。因此，对低成本治疗有效产出的需求不断增长，这一市场的基因组渗透率不断提高。PCR和微阵列技术由于引进了先进的设备，在基因组学领域也得到了迅速的发展，因为这些设备用于完成基因组学程序，是目标疾病市场中非常重要的组成部分。此外，微阵列用于测量人体组织和血液中存在的分析物，这将进一步为该行业带来丰厚的增长机会。此外，诸如试剂、样品制备试剂盒和生物标记物等消耗品在基因组学程序中被广泛使用。因此，由于在目标疾病管理中的重要应用，预计消耗品的使用也会增加。

Segment Analysis

The global genomics in cancer care market is segmented into product type, application, technology, and end use. On the basis of product type, the global market is sub segmented into consumables, instruments, and services. Instruments segment to hold the major market share owning to the increasing technological developments & advancements that support the growth digitalization in various PCR instruments for analyzing genome sequencing. While, consumable in the genomics market is observed to be the fastest growing segment during the forecast period.

Based on technology, the market is sub segmented into genome sequencing, PCR, microarray nucleic acid extraction and purification. Genomic sequencing to hold the major share in the market, owing to the accurate diagnosis and cost-effective treatment that gives an effective result. Similarly, this technique helps in discovering novel drugs, such as single nucleotide variants (SNVs), structural variants, and copy number changes. Furthermore, increasing use of this technology for the diagnosis of cancer, rising number of pertaining to technological advancements. It is also observed to be a flexible, cost-effective, and flexible driving the market of genomic sequencing segments market during the forecast period.

On the basis of application, the global genomics market is sub segmented into diagnostics, personalized medicines, drug delivery, and research. Diagnostics segment is observed to grow at a faster rate owning to the rising need for cancer diagnosis at an early stage, and rising awareness for genomics in cancer care. On the other hand, increasing research and development for developing novel drugs according to individual’s immunity would fuel the growth of personalized medicine segment during the forecast period.

研究所是市场最大的终端用户，在预测期内将占据主导地位。基因组学在癌症治疗中的市场增长主要是由于需要精确的筛选技术，从而实现癌症的定点诊断。

癌症护理市场范围内的基因组学

副产品	By Technology	By Application	按最终用途	By Region
Consumable 仪器 services	Gene Sequencing PCR 微阵列核酸的提取与纯化	Diagnostics 个性化药品 药物输送 研究	医院 研究机构 Academic Research	北美（美国、加拿大） 欧洲（德国、英国、法国、意大利、西班牙、比利时、俄罗斯、荷兰） Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines) 拉丁美洲（巴西、墨西哥、阿根廷） 中东和非洲（阿联酋、沙特阿拉伯、南非）

了解有关此报告的更多信息：样本页请求

区域分析

By geography, the global Market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is further segmented into U.S., and Canada. Europe is divided into Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest of Asia-Pacific.

就地理位置而言，北美在癌症治疗的基因组学方面占据了整个市场的主导地位。北美地区的增长主要是由越来越多的癌症患者、越来越多的政府和生物制药公司为开发新药提供资金以及该地区的主要参与者所推动。据估计，北美基因组学在癌症护理行业的收入约占38.4%的市场份额。

另一方面，由于印度和中国等国不断发展的医疗保健基础设施，亚太地区被认为增长较快。此外，改善的医疗基础设施、持续的政府支持和未开发的市场机会进一步为亚太地区市场创造了巨大的市场机会。yabo娱乐vip

Huge variety in the genetic deviations have been found in single type of cancer according to a complete study of cancer genomes and thus, discovery of uncommon genetic modifications is a challenge in the field of genomics. Moreover, another major challenge is to gain a best-quality biological sample that is essential for genomic training as well as studies, primarily for tumors that are rare and treated by surgical procedures.

竞争分析

该行业的主要运营商包括安捷伦科技公司、罗氏诊断公司、贝克曼库尔特公司、Illumina公司、Affymetrix公司、癌症基因公司、Bio-Rad实验室、太平洋生物科学公司、Sigma-Aldrich公司、GE医疗保健公司、Quest Diagnostics公司、雅培实验室、PerkinElmer公司和Luminex公司。这些领先企业正在市场上推出创新产品，以满足消费者日益增长的需求。全球企业正在进入发展中地区的新市场，以扩大其客户群，加强市场占yabo娱乐vip有率，并增加其在市场行业中的市场份额。